BioSpace News Archive

Aruna Bio, Inc. today announced preclinical results from a pilot study evaluating AB126 in a superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) mouse model.

Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, Chairman and CEO, will present a corporate overview with institutional investors during the H.C. Wainwright 25th Annual Global Investment Conference held the week of September 11th, 2023.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that management will present at H.C. Wainwright 25th Annual Global Investment Conference taking place September 11-13, 2023 in New York, NY.

Hyperfine, Inc. today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually.

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the H.C. Wainwright & Co. 25th Annual Global Investment Conference, taking place September 11-13, 2023.

Lumos Pharma, Inc. announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11th – 13th.

Syros Pharmaceuticals today announced the grant of restricted stock unit (RSU) awards for an aggregate of 20,650 shares of Syros common stock to two newly hired employees in connection with commencing employment with Syros.

Theralase Technologies Inc. is pleased to announce that it has closed a non-brokered private placement offering (“Offering”) of units (“Units”).

Centogene N.V., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, announced its unaudited financial results for the six months ended June 30, 2023.

Pleco Therapeutics BV, a specialty pharmaceutical company developing novel Plecoid™ therapies designed to detoxify the cancer microenvironment today announces the appointment of Dr Henno Welgemoed